List view / Grid view
8 August 2018 | By SUEZ
Data integrity and 21 CFR Part 11/EU Annex 11 requirements are hot topics when ageing analytical equipment is to be replaced. Common questions from pharma and biopharmaceutical manufacturers include: is the new technology compliant with auditor expectations? Can we get the right data saved the right way in the right…
7 August 2018 | By European Pharmaceutical Review
Researchers found that more than one quarter (26 per cent) of patients taking Aimovig 70mg were migraine free after month 15...
31 July 2018 | By Mike Stones
The detection of crystal nucleation has taken a step forward, after French scientists developed a new method of identification.
25 July 2018 | By Mike Stones
Boosting the safety of compounded drugs is the aim of new plan from the US Food and Drug Administration (FDA), which has unveiled a series of measures.
13 July 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of the NHS...
4 July 2018 | By European Pharmaceutical Review
Novel regimen enables physicians to fully dose up to two months of Aristada treatment on day one...
28 June 2018 | By Hyglos
The rapid ENDOZYME® II GO assay is the latest member of bioMérieux’s ENDONEXT™ range of endotoxin detection assays based on sustainable recombinant horseshoe crab Factor C (rFC). The new assay caters to two important needs: efficiency and consistency...
27 June 2018 | By bioMérieux
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXT™ range of recombinant horseshoe crab Factor C (rFC) assays.
28 May 2018 | By European Pharmaceutical Review
Novel enzyme therapy for adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment...
16 May 2018 | By European Pharmaceutical Review
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
25 April 2018 | By ACG group
ACG’s Capsules business will showcase their range of capsules solutions at CPhI North America, an international platform that brings together Pharma industry’s leaders from drug development, drug manufacturing and bio-manufacturing...
18 April 2018 | By European Pharmaceutical Review
The FDA has accepted for review the New Drug Application for ALKS 5461, a novel, once-daily, oral investigational medicine for the adjunctive treatment of major depressive disorder ...
3 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The EC has approved Alofisel for the treatment of complex perianal fistulae in adult patients with nonactive/mildly active luminal Crohn’s disease...
27 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so...
23 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy...
Send this to a friend
Follow: